Turnover—
EBIT margin—
Net result€18k+7435.3%
Working capital€18k+4211.4%
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Pithécanthrope is 0.2% (very low). The 2024 annual accounts show equity of €18k and a net result of €18k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 56% of 1234 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 4 annual accounts.
Financials
FY 2024
€18k
equity
Turnover—
Net result€18kHealth93/100 · Excellent
See full annual accounts
People & board
No director data processed yet.
To directors Publicationslatest 10-03-2025
1
publications in the State GazetteRegistered office moved from Pepinster to LiègeAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2021 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.2%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Higher-failure-rate region
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Activiteiten van medische laboratoria86901Activiteiten van medische beeldvorming en medische laboratoria86910
Primary activity highlighted.
Names & trade names
| Legal nameFR | Pithécanthrope |
Registered office
Avenue Blonden 46 bus 91
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.